Industry Research Reports
Home > Reports > Medical Devices & Consumables > Cell Therapy Manufacturing Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Cell Therapy Manufacturing Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-10-22
Pages: 120 Pages
Report ld: 4615795
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Cell Therapy Manufacturing Platform Market Size(US$)
CAGR 2025-2031
12.6%
Market Size,2031
USD 11,509
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 5,647 million
Market Forecast in 2031(Value)
US$ 11,509 million
CAGR
12.6%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Cell Therapy Manufacturing Platform was estimated to be worth US$ 5016 million in 2024 and is forecast to a readjusted size of US$ 11509 million by 2031 with a CAGR of 12.6% during the forecast period 2025-2031.
A Cell Therapy Manufacturing Platform refers to the integrated set of technologies, processes, and infrastructure used to produce cell-based therapies. These therapies involve using living cells to treat or prevent diseases, and the manufacturing platform ensures the cells are produced in a safe, efficient, and scalable manner.
The Cell Therapy Manufacturing Platform Market is experiencing robust growth, driven by advancements in biotechnology and increasing investment in regenerative medicine. Major sales regions include North America, Europe, and Asia-Pacific, with the U.S. and China leading due to their strong biopharmaceutical sectors and supportive regulatory environments. Market opportunities are abundant, particularly in personalized medicine and cancer treatment, where cell therapies show significant promise. However, the market faces challenges such as high manufacturing costs, complex production processes, and stringent regulatory requirements. Overcoming these hurdles is crucial for the broader adoption and commercialization of cell therapies, which are poised to revolutionize modern healthcare.
This report aims to provide a comprehensive presentation of the global market for Cell Therapy Manufacturing Platform, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cell Therapy Manufacturing Platform by region & country, by Type, and by Application.
The Cell Therapy Manufacturing Platform market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy Manufacturing Platform.
MARKET SEGMENTATION
By Company
- Cellares
- Miltenyi Biotec
- Cytiva
- Lonza
- Adva Biotechnology
- BioNTech
- 3M
- Ori Biotech
- Limula
- Resilience
- Cellistic
- Catalent
- Criver
- ElevateBio
- Ultragenyx
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Autologous Cell Therapies
- Allogeneic Cell Therapies
Segment by Application
- Oncology
- Cardiovascular Diseases
- Neurological Disorders
- Musculoskeletal Disorders
- Others
Segment by Category
- Distributed Manufacturing Platform
- Point of Care Manufacturing Platform
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cell Therapy Manufacturing Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cell Therapy Manufacturing Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cell Therapy Manufacturing Platform in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Cell Therapy Manufacturing Platform Product Introduction
1.2 Global Cell Therapy Manufacturing Platform Market Size Forecast (2020-2031)
1.3 Cell Therapy Manufacturing Platform Market Trends & Drivers
1.3.1 Cell Therapy Manufacturing Platform Industry Trends
1.3.2 Cell Therapy Manufacturing Platform Market Drivers & Opportunity
1.3.3 Cell Therapy Manufacturing Platform Market Challenges
1.3.4 Cell Therapy Manufacturing Platform Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cell Therapy Manufacturing Platform Players Revenue Ranking (2024)
2.2 Global Cell Therapy Manufacturing Platform Revenue by Company (2020-2025)
2.3 Key Companies Cell Therapy Manufacturing Platform Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cell Therapy Manufacturing Platform Product Offered
2.5 Key Companies Time to Begin Mass Production of Cell Therapy Manufacturing Platform
2.6 Cell Therapy Manufacturing Platform Market Competitive Analysis
2.6.1 Cell Therapy Manufacturing Platform Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Cell Therapy Manufacturing Platform Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Manufacturing Platform as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Autologous Cell Therapies
3.1.2 Allogeneic Cell Therapies
3.2 Global Cell Therapy Manufacturing Platform Sales Value by Type
3.2.1 Global Cell Therapy Manufacturing Platform Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Cell Therapy Manufacturing Platform Sales Value, by Type (2020-2031)
3.2.3 Global Cell Therapy Manufacturing Platform Sales Value, by Type (%) (2020-2031)
4 Segmentation by Manufacturing Mode
4.1 Introduction by Manufacturing Mode
4.1.1 Distributed Manufacturing Platform
4.1.2 Point of Care Manufacturing Platform
4.2 Global Cell Therapy Manufacturing Platform Sales Value by Manufacturing Mode
4.2.1 Global Cell Therapy Manufacturing Platform Sales Value by Manufacturing Mode (2020 VS 2024 VS 2031)
4.2.2 Global Cell Therapy Manufacturing Platform Sales Value, by Manufacturing Mode (2020-2031)
4.2.3 Global Cell Therapy Manufacturing Platform Sales Value, by Manufacturing Mode (%) (2020-2031)
5 Segmentation by Application
5.1 Introduction by Application
5.1.1 Oncology
5.1.2 Cardiovascular Diseases
5.1.3 Neurological Disorders
5.1.4 Musculoskeletal Disorders
5.1.5 Others
5.2 Global Cell Therapy Manufacturing Platform Sales Value by Application
5.2.1 Global Cell Therapy Manufacturing Platform Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Cell Therapy Manufacturing Platform Sales Value, by Application (2020-2031)
5.2.3 Global Cell Therapy Manufacturing Platform Sales Value, by Application (%) (2020-2031)
6 Segmentation by Region
6.1 Global Cell Therapy Manufacturing Platform Sales Value by Region
6.1.1 Global Cell Therapy Manufacturing Platform Sales Value by Region: 2020 VS 2024 VS 2031
6.1.2 Global Cell Therapy Manufacturing Platform Sales Value by Region (2020-2025)
6.1.3 Global Cell Therapy Manufacturing Platform Sales Value by Region (2026-2031)
6.1.4 Global Cell Therapy Manufacturing Platform Sales Value by Region (%), (2020-2031)
6.2 North America
6.2.1 North America Cell Therapy Manufacturing Platform Sales Value, 2020-2031
6.2.2 North America Cell Therapy Manufacturing Platform Sales Value by Country (%), 2024 VS 2031
6.3 Europe
6.3.1 Europe Cell Therapy Manufacturing Platform Sales Value, 2020-2031
6.3.2 Europe Cell Therapy Manufacturing Platform Sales Value by Country (%), 2024 VS 2031
6.4 Asia Pacific
6.4.1 Asia Pacific Cell Therapy Manufacturing Platform Sales Value, 2020-2031
6.4.2 Asia Pacific Cell Therapy Manufacturing Platform Sales Value by Region (%), 2024 VS 2031
6.5 South America
6.5.1 South America Cell Therapy Manufacturing Platform Sales Value, 2020-2031
6.5.2 South America Cell Therapy Manufacturing Platform Sales Value by Country (%), 2024 VS 2031
6.6 Middle East & Africa
6.6.1 Middle East & Africa Cell Therapy Manufacturing Platform Sales Value, 2020-2031
6.6.2 Middle East & Africa Cell Therapy Manufacturing Platform Sales Value by Country (%), 2024 VS 2031
7 Segmentation by Key Countries/Regions
7.1 Key Countries/Regions Cell Therapy Manufacturing Platform Sales Value Growth Trends, 2020 VS 2024 VS 2031
7.2 Key Countries/Regions Cell Therapy Manufacturing Platform Sales Value, 2020-2031
7.3 United States
7.3.1 United States Cell Therapy Manufacturing Platform Sales Value, 2020-2031
7.3.2 United States Cell Therapy Manufacturing Platform Sales Value by Type (%), 2024 VS 2031
7.3.3 United States Cell Therapy Manufacturing Platform Sales Value by Application, 2024 VS 2031
7.4 Europe
7.4.1 Europe Cell Therapy Manufacturing Platform Sales Value, 2020-2031
7.4.2 Europe Cell Therapy Manufacturing Platform Sales Value by Type (%), 2024 VS 2031
7.4.3 Europe Cell Therapy Manufacturing Platform Sales Value by Application, 2024 VS 2031
7.5 China
7.5.1 China Cell Therapy Manufacturing Platform Sales Value, 2020-2031
7.5.2 China Cell Therapy Manufacturing Platform Sales Value by Type (%), 2024 VS 2031
7.5.3 China Cell Therapy Manufacturing Platform Sales Value by Application, 2024 VS 2031
7.6 Japan
7.6.1 Japan Cell Therapy Manufacturing Platform Sales Value, 2020-2031
7.6.2 Japan Cell Therapy Manufacturing Platform Sales Value by Type (%), 2024 VS 2031
7.6.3 Japan Cell Therapy Manufacturing Platform Sales Value by Application, 2024 VS 2031
7.7 South Korea
7.7.1 South Korea Cell Therapy Manufacturing Platform Sales Value, 2020-2031
7.7.2 South Korea Cell Therapy Manufacturing Platform Sales Value by Type (%), 2024 VS 2031
7.7.3 South Korea Cell Therapy Manufacturing Platform Sales Value by Application, 2024 VS 2031
7.8 Southeast Asia
7.8.1 Southeast Asia Cell Therapy Manufacturing Platform Sales Value, 2020-2031
7.8.2 Southeast Asia Cell Therapy Manufacturing Platform Sales Value by Type (%), 2024 VS 2031
7.8.3 Southeast Asia Cell Therapy Manufacturing Platform Sales Value by Application, 2024 VS 2031
7.9 India
7.9.1 India Cell Therapy Manufacturing Platform Sales Value, 2020-2031
7.9.2 India Cell Therapy Manufacturing Platform Sales Value by Type (%), 2024 VS 2031
7.9.3 India Cell Therapy Manufacturing Platform Sales Value by Application, 2024 VS 2031
8 Company Profiles
8.1 Cellares
8.1.1 Cellares Profile
8.1.2 Cellares Main Business
8.1.3 Cellares Cell Therapy Manufacturing Platform Products, Services and Solutions
8.1.4 Cellares Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.1.5 Cellares Recent Developments
8.2 Miltenyi Biotec
8.2.1 Miltenyi Biotec Profile
8.2.2 Miltenyi Biotec Main Business
8.2.3 Miltenyi Biotec Cell Therapy Manufacturing Platform Products, Services and Solutions
8.2.4 Miltenyi Biotec Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.2.5 Miltenyi Biotec Recent Developments
8.3 Cytiva
8.3.1 Cytiva Profile
8.3.2 Cytiva Main Business
8.3.3 Cytiva Cell Therapy Manufacturing Platform Products, Services and Solutions
8.3.4 Cytiva Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.3.5 Cytiva Recent Developments
8.4 Lonza
8.4.1 Lonza Profile
8.4.2 Lonza Main Business
8.4.3 Lonza Cell Therapy Manufacturing Platform Products, Services and Solutions
8.4.4 Lonza Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.4.5 Lonza Recent Developments
8.5 Adva Biotechnology
8.5.1 Adva Biotechnology Profile
8.5.2 Adva Biotechnology Main Business
8.5.3 Adva Biotechnology Cell Therapy Manufacturing Platform Products, Services and Solutions
8.5.4 Adva Biotechnology Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.5.5 Adva Biotechnology Recent Developments
8.6 BioNTech
8.6.1 BioNTech Profile
8.6.2 BioNTech Main Business
8.6.3 BioNTech Cell Therapy Manufacturing Platform Products, Services and Solutions
8.6.4 BioNTech Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.6.5 BioNTech Recent Developments
8.7 3M
8.7.1 3M Profile
8.7.2 3M Main Business
8.7.3 3M Cell Therapy Manufacturing Platform Products, Services and Solutions
8.7.4 3M Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.7.5 3M Recent Developments
8.8 Ori Biotech
8.8.1 Ori Biotech Profile
8.8.2 Ori Biotech Main Business
8.8.3 Ori Biotech Cell Therapy Manufacturing Platform Products, Services and Solutions
8.8.4 Ori Biotech Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.8.5 Ori Biotech Recent Developments
8.9 Limula
8.9.1 Limula Profile
8.9.2 Limula Main Business
8.9.3 Limula Cell Therapy Manufacturing Platform Products, Services and Solutions
8.9.4 Limula Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.9.5 Limula Recent Developments
8.10 Resilience
8.10.1 Resilience Profile
8.10.2 Resilience Main Business
8.10.3 Resilience Cell Therapy Manufacturing Platform Products, Services and Solutions
8.10.4 Resilience Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.10.5 Resilience Recent Developments
8.11 Cellistic
8.11.1 Cellistic Profile
8.11.2 Cellistic Main Business
8.11.3 Cellistic Cell Therapy Manufacturing Platform Products, Services and Solutions
8.11.4 Cellistic Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.11.5 Cellistic Recent Developments
8.12 Catalent
8.12.1 Catalent Profile
8.12.2 Catalent Main Business
8.12.3 Catalent Cell Therapy Manufacturing Platform Products, Services and Solutions
8.12.4 Catalent Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.12.5 Catalent Recent Developments
8.13 Criver
8.13.1 Criver Profile
8.13.2 Criver Main Business
8.13.3 Criver Cell Therapy Manufacturing Platform Products, Services and Solutions
8.13.4 Criver Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.13.5 Criver Recent Developments
8.14 ElevateBio
8.14.1 ElevateBio Profile
8.14.2 ElevateBio Main Business
8.14.3 ElevateBio Cell Therapy Manufacturing Platform Products, Services and Solutions
8.14.4 ElevateBio Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.14.5 ElevateBio Recent Developments
8.15 Ultragenyx
8.15.1 Ultragenyx Profile
8.15.2 Ultragenyx Main Business
8.15.3 Ultragenyx Cell Therapy Manufacturing Platform Products, Services and Solutions
8.15.4 Ultragenyx Cell Therapy Manufacturing Platform Revenue (US$ Million) & (2020-2025)
8.15.5 Ultragenyx Recent Developments
9 Industry Chain Analysis
9.1 Cell Therapy Manufacturing Platform Industrial Chain
9.2 Cell Therapy Manufacturing Platform Upstream Analysis
9.2.1 Key Raw Materials
9.2.2 Raw Materials Key Suppliers
9.2.3 Manufacturing Cost Structure
9.3 Midstream Analysis
9.4 Downstream Analysis (Customers Analysis)
9.5 Sales Model and Sales Channels
9.5.1 Cell Therapy Manufacturing Platform Sales Model
9.5.2 Sales Channel
9.5.3 Cell Therapy Manufacturing Platform Distributors
10 Research Findings and Conclusion
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Author Details
11.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Cell Therapy Manufacturing Platform Market Trends
Table 2. Cell Therapy Manufacturing Platform Market Drivers & Opportunity
Table 3. Cell Therapy Manufacturing Platform Market Challenges
Table 4. Cell Therapy Manufacturing Platform Market Restraints
Table 5. Global Cell Therapy Manufacturing Platform Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Cell Therapy Manufacturing Platform Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Cell Therapy Manufacturing Platform Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cell Therapy Manufacturing Platform Product Type
Table 9. Key Companies Time to Begin Mass Production of Cell Therapy Manufacturing Platform
Table 10. Global Cell Therapy Manufacturing Platform Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Manufacturing Platform as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cell Therapy Manufacturing Platform Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Cell Therapy Manufacturing Platform Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Cell Therapy Manufacturing Platform Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Cell Therapy Manufacturing Platform Sales Market Share in Value by Type (2020-2025)
Table 17. Global Cell Therapy Manufacturing Platform Sales Market Share in Value by Type (2026-2031)
Table 18. Global Cell Therapy Manufacturing Platform Sales Value by Manufacturing Mode: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Cell Therapy Manufacturing Platform Sales Value by Manufacturing Mode (2020-2025) & (US$ Million)
Table 20. Global Cell Therapy Manufacturing Platform Sales Value by Manufacturing Mode (2026-2031) & (US$ Million)
Table 21. Global Cell Therapy Manufacturing Platform Sales Market Share in Value by Manufacturing Mode (2020-2025)
Table 22. Global Cell Therapy Manufacturing Platform Sales Market Share in Value by Manufacturing Mode (2026-2031)
Table 23. Global Cell Therapy Manufacturing Platform Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 24. Global Cell Therapy Manufacturing Platform Sales Value by Application (2020-2025) & (US$ Million)
Table 25. Global Cell Therapy Manufacturing Platform Sales Value by Application (2026-2031) & (US$ Million)
Table 26. Global Cell Therapy Manufacturing Platform Sales Market Share in Value by Application (2020-2025)
Table 27. Global Cell Therapy Manufacturing Platform Sales Market Share in Value by Application (2026-2031)
Table 28. Global Cell Therapy Manufacturing Platform Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 29. Global Cell Therapy Manufacturing Platform Sales Value by Region (2020-2025) & (US$ Million)
Table 30. Global Cell Therapy Manufacturing Platform Sales Value by Region (2026-2031) & (US$ Million)
Table 31. Global Cell Therapy Manufacturing Platform Sales Value by Region (2020-2025) & (%)
Table 32. Global Cell Therapy Manufacturing Platform Sales Value by Region (2026-2031) & (%)
Table 33. Key Countries/Regions Cell Therapy Manufacturing Platform Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 34. Key Countries/Regions Cell Therapy Manufacturing Platform Sales Value, (2020-2025) & (US$ Million)
Table 35. Key Countries/Regions Cell Therapy Manufacturing Platform Sales Value, (2026-2031) & (US$ Million)
Table 36. Cellares Basic Information List
Table 37. Cellares Description and Business Overview
Table 38. Cellares Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of Cellares (2020-2025)
Table 40. Cellares Recent Developments
Table 41. Miltenyi Biotec Basic Information List
Table 42. Miltenyi Biotec Description and Business Overview
Table 43. Miltenyi Biotec Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of Miltenyi Biotec (2020-2025)
Table 45. Miltenyi Biotec Recent Developments
Table 46. Cytiva Basic Information List
Table 47. Cytiva Description and Business Overview
Table 48. Cytiva Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of Cytiva (2020-2025)
Table 50. Cytiva Recent Developments
Table 51. Lonza Basic Information List
Table 52. Lonza Description and Business Overview
Table 53. Lonza Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of Lonza (2020-2025)
Table 55. Lonza Recent Developments
Table 56. Adva Biotechnology Basic Information List
Table 57. Adva Biotechnology Description and Business Overview
Table 58. Adva Biotechnology Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of Adva Biotechnology (2020-2025)
Table 60. Adva Biotechnology Recent Developments
Table 61. BioNTech Basic Information List
Table 62. BioNTech Description and Business Overview
Table 63. BioNTech Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of BioNTech (2020-2025)
Table 65. BioNTech Recent Developments
Table 66. 3M Basic Information List
Table 67. 3M Description and Business Overview
Table 68. 3M Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of 3M (2020-2025)
Table 70. 3M Recent Developments
Table 71. Ori Biotech Basic Information List
Table 72. Ori Biotech Description and Business Overview
Table 73. Ori Biotech Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of Ori Biotech (2020-2025)
Table 75. Ori Biotech Recent Developments
Table 76. Limula Basic Information List
Table 77. Limula Description and Business Overview
Table 78. Limula Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of Limula (2020-2025)
Table 80. Limula Recent Developments
Table 81. Resilience Basic Information List
Table 82. Resilience Description and Business Overview
Table 83. Resilience Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of Resilience (2020-2025)
Table 85. Resilience Recent Developments
Table 86. Cellistic Basic Information List
Table 87. Cellistic Description and Business Overview
Table 88. Cellistic Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of Cellistic (2020-2025)
Table 90. Cellistic Recent Developments
Table 91. Catalent Basic Information List
Table 92. Catalent Description and Business Overview
Table 93. Catalent Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 94. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of Catalent (2020-2025)
Table 95. Catalent Recent Developments
Table 96. Criver Basic Information List
Table 97. Criver Description and Business Overview
Table 98. Criver Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 99. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of Criver (2020-2025)
Table 100. Criver Recent Developments
Table 101. ElevateBio Basic Information List
Table 102. ElevateBio Description and Business Overview
Table 103. ElevateBio Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 104. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of ElevateBio (2020-2025)
Table 105. ElevateBio Recent Developments
Table 106. Ultragenyx Basic Information List
Table 107. Ultragenyx Description and Business Overview
Table 108. Ultragenyx Cell Therapy Manufacturing Platform Products, Services and Solutions
Table 109. Revenue (US$ Million) in Cell Therapy Manufacturing Platform Business of Ultragenyx (2020-2025)
Table 110. Ultragenyx Recent Developments
Table 111. Key Raw Materials Lists
Table 112. Raw Materials Key Suppliers Lists
Table 113. Cell Therapy Manufacturing Platform Downstream Customers
Table 114. Cell Therapy Manufacturing Platform Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Cell Therapy Manufacturing Platform Product Picture
Figure 2. Global Cell Therapy Manufacturing Platform Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Cell Therapy Manufacturing Platform Sales Value (2020-2031) & (US$ Million)
Figure 4. Cell Therapy Manufacturing Platform Report Years Considered
Figure 5. Global Cell Therapy Manufacturing Platform Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Cell Therapy Manufacturing Platform Revenue in 2024
Figure 7. Cell Therapy Manufacturing Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Autologous Cell Therapies Picture
Figure 9. Allogeneic Cell Therapies Picture
Figure 10. Global Cell Therapy Manufacturing Platform Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 11. Global Cell Therapy Manufacturing Platform Sales Value Market Share by Type, 2024 & 2031
Figure 12. Distributed Manufacturing Platform Picture
Figure 13. Point of Care Manufacturing Platform Picture
Figure 14. Global Cell Therapy Manufacturing Platform Sales Value by Manufacturing Mode (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Cell Therapy Manufacturing Platform Sales Value Market Share by Manufacturing Mode, 2024 & 2031
Figure 16. Product Picture of Oncology
Figure 17. Product Picture of Cardiovascular Diseases
Figure 18. Product Picture of Neurological Disorders
Figure 19. Product Picture of Musculoskeletal Disorders
Figure 20. Product Picture of Others
Figure 21. Global Cell Therapy Manufacturing Platform Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Cell Therapy Manufacturing Platform Sales Value Market Share by Application, 2024 & 2031
Figure 23. North America Cell Therapy Manufacturing Platform Sales Value (2020-2031) & (US$ Million)
Figure 24. North America Cell Therapy Manufacturing Platform Sales Value by Country (%), 2024 VS 2031
Figure 25. Europe Cell Therapy Manufacturing Platform Sales Value, (2020-2031) & (US$ Million)
Figure 26. Europe Cell Therapy Manufacturing Platform Sales Value by Country (%), 2024 VS 2031
Figure 27. Asia Pacific Cell Therapy Manufacturing Platform Sales Value, (2020-2031) & (US$ Million)
Figure 28. Asia Pacific Cell Therapy Manufacturing Platform Sales Value by Region (%), 2024 VS 2031
Figure 29. South America Cell Therapy Manufacturing Platform Sales Value, (2020-2031) & (US$ Million)
Figure 30. South America Cell Therapy Manufacturing Platform Sales Value by Country (%), 2024 VS 2031
Figure 31. Middle East & Africa Cell Therapy Manufacturing Platform Sales Value, (2020-2031) & (US$ Million)
Figure 32. Middle East & Africa Cell Therapy Manufacturing Platform Sales Value by Country (%), 2024 VS 2031
Figure 33. Key Countries/Regions Cell Therapy Manufacturing Platform Sales Value (%), (2020-2031)
Figure 34. United States Cell Therapy Manufacturing Platform Sales Value, (2020-2031) & (US$ Million)
Figure 35. United States Cell Therapy Manufacturing Platform Sales Value by Type (%), 2024 VS 2031
Figure 36. United States Cell Therapy Manufacturing Platform Sales Value by Application (%), 2024 VS 2031
Figure 37. Europe Cell Therapy Manufacturing Platform Sales Value, (2020-2031) & (US$ Million)
Figure 38. Europe Cell Therapy Manufacturing Platform Sales Value by Type (%), 2024 VS 2031
Figure 39. Europe Cell Therapy Manufacturing Platform Sales Value by Application (%), 2024 VS 2031
Figure 40. China Cell Therapy Manufacturing Platform Sales Value, (2020-2031) & (US$ Million)
Figure 41. China Cell Therapy Manufacturing Platform Sales Value by Type (%), 2024 VS 2031
Figure 42. China Cell Therapy Manufacturing Platform Sales Value by Application (%), 2024 VS 2031
Figure 43. Japan Cell Therapy Manufacturing Platform Sales Value, (2020-2031) & (US$ Million)
Figure 44. Japan Cell Therapy Manufacturing Platform Sales Value by Type (%), 2024 VS 2031
Figure 45. Japan Cell Therapy Manufacturing Platform Sales Value by Application (%), 2024 VS 2031
Figure 46. South Korea Cell Therapy Manufacturing Platform Sales Value, (2020-2031) & (US$ Million)
Figure 47. South Korea Cell Therapy Manufacturing Platform Sales Value by Type (%), 2024 VS 2031
Figure 48. South Korea Cell Therapy Manufacturing Platform Sales Value by Application (%), 2024 VS 2031
Figure 49. Southeast Asia Cell Therapy Manufacturing Platform Sales Value, (2020-2031) & (US$ Million)
Figure 50. Southeast Asia Cell Therapy Manufacturing Platform Sales Value by Type (%), 2024 VS 2031
Figure 51. Southeast Asia Cell Therapy Manufacturing Platform Sales Value by Application (%), 2024 VS 2031
Figure 52. India Cell Therapy Manufacturing Platform Sales Value, (2020-2031) & (US$ Million)
Figure 53. India Cell Therapy Manufacturing Platform Sales Value by Type (%), 2024 VS 2031
Figure 54. India Cell Therapy Manufacturing Platform Sales Value by Application (%), 2024 VS 2031
Figure 55. Cell Therapy Manufacturing Platform Industrial Chain
Figure 56. Cell Therapy Manufacturing Platform Manufacturing Cost Structure
Figure 57. Channels of Distribution (Direct Sales, and Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Cell Therapy Manufacturing Platform in 2025?
The global market size of Cell Therapy Manufacturing Platform in 2025 was 5647 Million USD.
What is the annual compound growth rate of the global Cell Therapy Manufacturing Platform market size from 2025 to 2031?
What was the global market size of Cell Therapy Manufacturing Platform in 2031?
Which region is expected to have the highest market share?
Which companies rank high in the global Cell Therapy Manufacturing Platform market?
Related Reports
Global Cell Therapy Manufacturing Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cell Therapy Manufacturing Platform market is projected to grow from US$ 5647 million in 2025 to US$ 12810 million by 2032, at a CAGR of 12.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 142
USD 4900.00
(Single User License)
Global Cell Therapy Manufacturing Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell Therapy Manufacturing Platform market size was US$ 5647 million in 2025 and is forecast to reach a readjusted size of US$ 12810 million by 2032 with a CAGR of 12.6% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 94
USD 4250.00
(Single User License)
Cell Therapy Manufacturing Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell Therapy Manufacturing Platform was estimated to be worth US$ 5647 million in 2025 and is projected to reach US$ 12810 million, growing at a CAGR of 12.6% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 110
USD 3950.00
(Single User License)
Global Cell Therapy Manufacturing Platform Market Research Report 2026
The global Cell Therapy Manufacturing Platform market was valued at US$ 5647 million in 2025 and is anticipated to reach US$ 12810 million by 2032, at a CAGR of 12.6% from 2026 to 2032.
Published Date: 2026-01-14
Pages: 111
USD 2900.00
(Single User License)
Global Cell Therapy Manufacturing Platform Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell Therapy Manufacturing Platform market is projected to grow from US$ 5016 million in 2024 to US$ 11509 million by 2031, at a CAGR of 12.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-22
Pages: 144
USD 4900.00
(Single User License)
Global Cell Therapy Manufacturing Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell Therapy Manufacturing Platform market size was US$ 5016 million in 2024 and is forecast to a readjusted size of US$ 11509 million by 2031 with a CAGR of 12.6% during the forecast period 2025-2031.
Published Date: 2025-10-22
Pages: 98
USD 4250.00
(Single User License)
Global Cell Therapy Manufacturing Platform Market Research Report 2025
The global market for Cell Therapy Manufacturing Platform was valued at US$ 5016 million in the year 2024 and is projected to reach a revised size of US$ 11509 million by 2031, growing at a CAGR of 12.6% during the forecast period.
Published Date: 2025-10-22
Pages: 81
USD 2900.00
(Single User License)
Global Cell Therapy Manufacturing Platform Market Insights, Forecast to 2030
A Cell Therapy Manufacturing Platform refers to the integrated set of technologies, processes, and infrastructure used to produce cell-based therapies. These therapies involve using living cells to treat or prevent diseases, and the manufacturing platform ensures the cells are produced in a safe, efficient, and scalable manner.
Published Date: 2024-06-15
Pages: 141
USD 4900.00
(Single User License)
Global Cell Therapy Manufacturing Platform Market Research Report 2024
A Cell Therapy Manufacturing Platform refers to the integrated set of technologies, processes, and infrastructure used to produce cell-based therapies. These therapies involve using living cells to treat or prevent diseases, and the manufacturing platform ensures the cells are produced in a safe, efficient, and scalable manner.
Published Date: 2024-06-15
Pages: 88
USD 2900.00
(Single User License)
Global and United States Cell Therapy Manufacturing Platform Market Report & Forecast 2024-2030
A Cell Therapy Manufacturing Platform refers to the integrated set of technologies, processes, and infrastructure used to produce cell-based therapies. These therapies involve using living cells to treat or prevent diseases, and the manufacturing platform ensures the cells are produced in a safe, efficient, and scalable manner.
Published Date: 2024-06-15
Pages: 119
USD 4350.00
(Single User License)
Global Cell Therapy Manufacturing Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cell Therapy Manufacturing Platform market is projected to grow from US$ 5647 million in 2025 to US$ 12810 million by 2032, at a CAGR of 12.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 142
USD 4900.00 (Single User License)Global Cell Therapy Manufacturing Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell Therapy Manufacturing Platform market size was US$ 5647 million in 2025 and is forecast to reach a readjusted size of US$ 12810 million by 2032 with a CAGR of 12.6% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 94
USD 4250.00 (Single User License)Cell Therapy Manufacturing Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell Therapy Manufacturing Platform was estimated to be worth US$ 5647 million in 2025 and is projected to reach US$ 12810 million, growing at a CAGR of 12.6% from 2026 to 2032.
Published: 2026-01-19
Pages: 110
USD 3950.00 (Single User License)Global Cell Therapy Manufacturing Platform Market Research Report 2026
The global Cell Therapy Manufacturing Platform market was valued at US$ 5647 million in 2025 and is anticipated to reach US$ 12810 million by 2032, at a CAGR of 12.6% from 2026 to 2032.
Published: 2026-01-14
Pages: 111
USD 2900.00 (Single User License)Global Cell Therapy Manufacturing Platform Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell Therapy Manufacturing Platform market is projected to grow from US$ 5016 million in 2024 to US$ 11509 million by 2031, at a CAGR of 12.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-22
Pages: 144
USD 4900.00 (Single User License)Global Cell Therapy Manufacturing Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell Therapy Manufacturing Platform market size was US$ 5016 million in 2024 and is forecast to a readjusted size of US$ 11509 million by 2031 with a CAGR of 12.6% during the forecast period 2025-2031.
Published: 2025-10-22
Pages: 98
USD 4250.00 (Single User License)Global Cell Therapy Manufacturing Platform Market Research Report 2025
The global market for Cell Therapy Manufacturing Platform was valued at US$ 5016 million in the year 2024 and is projected to reach a revised size of US$ 11509 million by 2031, growing at a CAGR of 12.6% during the forecast period.
Published: 2025-10-22
Pages: 81
USD 2900.00 (Single User License)Global Cell Therapy Manufacturing Platform Market Insights, Forecast to 2030
A Cell Therapy Manufacturing Platform refers to the integrated set of technologies, processes, and infrastructure used to produce cell-based therapies. These therapies involve using living cells to treat or prevent diseases, and the manufacturing platform ensures the cells are produced in a safe, efficient, and scalable manner.
Published: 2024-06-15
Pages: 141
USD 4900.00 (Single User License)Global Cell Therapy Manufacturing Platform Market Research Report 2024
A Cell Therapy Manufacturing Platform refers to the integrated set of technologies, processes, and infrastructure used to produce cell-based therapies. These therapies involve using living cells to treat or prevent diseases, and the manufacturing platform ensures the cells are produced in a safe, efficient, and scalable manner.
Published: 2024-06-15
Pages: 88
USD 2900.00 (Single User License)Global and United States Cell Therapy Manufacturing Platform Market Report & Forecast 2024-2030
A Cell Therapy Manufacturing Platform refers to the integrated set of technologies, processes, and infrastructure used to produce cell-based therapies. These therapies involve using living cells to treat or prevent diseases, and the manufacturing platform ensures the cells are produced in a safe, efficient, and scalable manner.
Published: 2024-06-15
Pages: 119
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now